Allergy reviews series II: Recombinant allergens

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue 6, 1998, Pages 552-561

  Valenta, R ^a,b   Vrtala, S ^a   Laffer, S ^a   Spitzauer, S ^a   Kraft, D ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Allergy; cDNA cloning; Diagnosis; Immunotherapy; Recombinant allergens

Indexed keywords

ALLERGEN; COMPLEMENTARY DNA; CROSS REACTING ANTIGEN; EPITOPE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; POLLEN ANTIGEN; POLLEN EXTRACT; PROFILIN; DIAGNOSTIC AGENT; RECOMBINANT DNA; RECOMBINANT PROTEIN;

ANAPHYLAXIS; ANTIGEN RECOGNITION; B LYMPHOCYTE; DNA TEMPLATE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOGENICITY; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; REVIEW; T LYMPHOCYTE; ANIMAL; BIOTECHNOLOGY; DESENSITIZATION; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY;

ALLERGENS; ANIMALS; BIOTECHNOLOGY; DESENSITIZATION, IMMUNOLOGIC; DNA, RECOMBINANT; HUMANS; HYPERSENSITIVITY; RECOMBINANT PROTEINS;

EID: 0032085315     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb03930.x     Document Type: Review

References (92)

1. Scheiner O, Kraft D. Basic and practical aspects of recombinant allergens. Allergy 1995;50:384-91.
2. Valenta R, Kraft D. Recombinant allergens for diagnosis and therapy of allergic diseases. Curr Opin Immunol 1995;7:751-6.
3. Valenta R, Steinberger P, Duchêne M, Kraft D. Immunological similarities among allergens: prerequisite for a specific and component based therapy of allergy. Immunol Cell Biol 1996;74:187-94.
4. Bousquet J, Valenta R. In vivo and in vitro use of recombinant allergens. Allergy Clin Immunol News 1994;6:54-9.
5. Valenta R, Yssel H, Plaut M, Goldstein RJ, Kraft D. The future of immunotherapy: therapeutic vaccines. Allergy 1998;53:in press.
6. Baldo B, Donovan GR. The structural basis of allergenicity: recombinant DNA-based strategies for the study of allergens. Allergy 1989;44:81-97.
7. Breitenbach M, Valenta R, Breiteneder H, et al. Introduction to cDNA cloning of plant allergens. In: Schon AH, Kraft D, Kunkel G, editors. Epitopes of atopic allergens. Brussels: UCB Institute of Allergy, 1990:57-9.
8. Breiteneder H, Ferreira F, Hoffmann-Sommergruber K, et al. Four recombinant isoforms of Cor a 1, the major allergen of hazel pollen, show different IgE-binding properties. Eur J Biochem 1993;212:355-62.
9. Swoboda I, Jilek A, Ferreira F, et al. Isoforms of Bet v 1, the major birch pollen allergen, analyzed by liquid chromatography, mass spectrometry, and cDNA cloning. J Biol Chem 1995;270:2607-13.
10. Ferreira F, Hirtenlehner K, Jilek A, et al. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J Exp Med 1996;183:599-609.
11. Breiteneder H, Hassfeld W, Pettenburger K, et al. Isolation and characterization of messenger RNA from male inflorescences and pollen of the white birch (Betula verrucosa). Int Arch Allergy Appl Immunol 1988;87:19-24.
12. Breiteneder H, Pettenburger K, Bito A, et al. The gene coding for the major birch pollen allergen Bet v I is highly homologous to a pea disease resistance response gene. EMBO J 1989;8:1935-9.
13. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 1990;185:60-89.
14. Valenta R, Duchêne M, Vrtala S, et al. Recombinant allergens for immunoblot diagnosis of tree-pollen allergy. J Allergy Clin Immunol 1991;88:889-94.
15. Valenta R, Vrtala S, Ebner C, Kraft D, Scheiner O. Diagnosis of grass pollen allergy with recombinant timothy grass (Phleum pratense) pollen allergens. Int Arch Allergy Immunol 1992;97:287-94.
16. Ebner C, Ferreira F, Szephalusi Z, et al. Identification of multiple T-cell epitopes on Bet v 1, the major birch pollen allergen using specific T cell clones and overlapping peptides. J Immunol 1993;2150:1047-54.
17. Valenta R, Sperr WR, Ferreira F, et al. Induction of specific histamine release from basophils with purified natural and recombinant birch pollen allergens. J Allergy Clin Immunol 1993;91:88-97.
18. Sehon AH, Mohapatra SS. Induction of IgE antibodies in mice with recombinant grass pollen antigens. Immunology 1992;76:158-63.
19. Ferreira F, Mayer P, Sperr WR, et al. Induction of IgE antibodies with predefined specificity in rhesus monkeys with recombinant birch pollen allergens, Bet v 1 and Bet v 2. J Allergy Clin Immunol 1996;97:95-103.
20. Vrtala S, Mayer P, Ferreira F, et al. Induction of IgE antibodies in mice and rhesus monkeys with recombinant birch pollen allergens; different allergenicity of Bet v 1 and Bet v 2. J Allergy Clin Immunol 1996;98: 913-21.
21. Moser M, Crameri R, Brust E, Suter M, Menz G. Diagnostic value of recombinant Aspergillus fumigatus allergen I/ a for skin testing and serology. J Allergy Clin Immunol 1994;93:1-11.
22. 2 from honeybee venom is similar. J Allergy Clin Immunol 1995;96:395-402.
23. Menz G, Dolecek C, Schönheit-Kenn U, et al. Serological and skin-test diagnosis of birch pollen allergy with recombinant Bet v 1, the major birch pollen allergen. Clin Exp Allergy 1996;26:50-60.
24. Pauli G, Oster JP, Deviller P, et al. Skin testing with recombinant allergens rBet v 1 and birch profilin, rBet v 2: diagnostic value for birch pollen and associated allergies. J Allergy Clin Immunol 1996;97:1100-9.
25. Lynch NR, Thomas WR, Chua Y, Garcia N, Diprisco MC, Lopez R. In vivo biological activity of recombinant Der p 2 allergen of house dust mite. Int Arch Allergy Immunol 1994;105:70-4.
26. Sidoli A, Tamborini E, Giuntini I, et al. Cloning, expression, and immunological characterization of recombinant Lolium perenne allergen Lol p 2. J Biol Chem 1993;268:21819-25.
27. Higgins JA, Thorpe CJ, Hayball JD, O'Hehir RE, Lamb J. Overlapping T-cell epitopes in the group I allergens of Dermatophagoides species restricted by HLA-DP and HLA-DR class II molecules. J Allergy Clin Immunol 1994;93:891-9.
28. Bungy GA, Rodda S, Roitt I, Brostoff J. Mapping of T-cell epitopes of the major fraction of ryegrass using peripheral blood mononuclear cells from atopies and non-atopics. II. Isoallergen clone 5A of Lolium perenne group I (Lol p 1). Eur J Immunol 1994;24:2098-2103.
29. Schenk S, Breiteneder H, Susani M, et al. T-cell epitopes of Phl p 1, major pollen allergen of timothy grass (Phleum pratense): evidence for crossreacting and non-crossreacting T-cell epitopes within grass group I allergens. J Allergy Clin Immunol 1995;96:989-96.
30. Ebner C, Schenk S, Najafian N, et al. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. J Immunol 1995;154:1932-40.
31. van-Neerven RJ, van de Pol MM, Wierenga EA, Aalberse RC, Jansen HM, Kapsenberg ML. Peptide specificity and HLA restriction do not dictate lymphokine production by allergen-specific T-lymphocyte clones. Immunology 1994; 82:351-6.
32. Norman PS. Modern concepts of immunotherapy. Curr Opin Immunol 1993;5:968-73.
33. Sheffer AL. Allergen-specific immunotherapy: a role for T-cell anergy. Ann Allergy 1993;71:327-9.
34. Yssel H, Fasler S, Lamb J, de Vries JE. Induction of non-responsiveness in human allergen-specific type 2 T helper cells. Curr Opin Immunol 1994;6:847-52.
35. Briner TJ, Kuo MC, Keating KM, Rogers BL, Greenstein JL. Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d 1. Proc Natl Acad Sci U S A 1993;90: 7608-12.
36. Hoyne GF, O'Hehir RE, Wraith DC, Thomas WR, Lamb JR. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T epitope in naive and sensitized mice. J Exp Med 1993;178:1783-8.
37. Ball T, Vrtala S, Sperr WR, et al. Isolation of an immunodominant IgE hapten from an expression cDNA library. J Biol Chem 1994;269:28323-8.
38. Greene WK, Cyster JG, Chua KY, O'Brien RM, Thomas WR. IgE and IgG binding of peptides expressed from fragments of cDNA encoding the major house dust mite allergen Der p I. J Immunol 1991;147:3768-73.
39. Ong EK, Knox RB, Singh MB. Mapping of the antigenic and allergenic epitopes of Lol p VB using gene fragmentation. Mol Immunol 1995;32:295-302.
40. Fedorov AA, Ball T, Mahoney NM, Valenta R, Almo SC. The molecular basis for allergen cross-reactivity: crystal structure and IgE-epitope mapping of birch pollen profilin. Structure 1997;5:33-45.
41. Vrtala S, Hirtenlehner K, Vangelista L, et al. Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments. J Clin Invest 1997;99:1673-81.
42. Gajhede M, Osmark P, Poulsen FM, et al. X-ray and NMR structure of Bet v 1, the origin of birch pollen allergy. Nat Struct Biol 1996;3:1040-5.
43. del Prete GF, Maggi E, Parronchi P, et al. IL-4 is an essential factor for the IgE-synthesis induced in vitro by human T-cell clones and their supernatants. J Immunol 1988;140:4193-8.
44. Pene J, Rousset F, Brierel F, et al. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-γ. J Immunol 1988;141:1218-24.
45. de Vries JE, Gauchat JF, Aversa GG, et al. Regulation of IgE synthesis by cytokines. Curr Opin Immunol 1991;3: 851-8.
46. Minty A, Chalon P, Derocq JM, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune response. Nature 1993;362:248-50.
47. de Vries J. Novel fundamental approaches to intervening in IgE-mediated allergic diseases. J Invest Dermatol 1994;102:141-4.
48. Steinberger P, Bohle B, di Padova F, et al. Allergen-specific IgE production of committed B cells from allergic patients in vitro. J Allergy Clin Immunol 1995;96:209-18.
49. Dolecek C, Steinberger P, Susani M, Kraft D, Valenta R, Boltz-Nitulescu G. Effects of IL-4 and IL-13 on total and allergen specific IgE production by cultured PBMC from allergic patients determined with recombinant pollen allergens. Clin Exp Allergy 1995;25:879-89.
50. Valenta R, Duchêne M, Pettenburger K, et al. Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals. Science 1991;253:557-60.
51. Valenta R, Duchêne M, Ebner C, et al. Profilins constitute a novel family of functional plant pan-allergens. J Exp Med 1992;175:377-85.
52. Hirschwehr R, Valenta R, Ebner C, et al. Identification of common allergenic structures in hazel pollen and hazelnuts: a possible explanation for sensitivity to hazelnuts in patients allergic to tree pollen. J Allergy Clin Immunol 1992;90:927-36.
53. Ebner C, Hirschwehr R, Bauer L, et al. Identification of allergens in fruits and vegetables, IgE-crossreactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin). J Allergy Clin Immunol 1995;95:962-9.
54. Valenta R, Kraft D. Type I allergic reactions to plant-derived food: a consequence of primary sensitization to pollen allergens. J Allergy Clin Immunol 1996;97:893-5.
55. Vrtala S, Sperr WR, Reimitzer I, et al. cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen: characterization of the recombinant Phl p 5 allergen. J Immunol 1993;150:1047-54.
56. Laffer S, Vrtala S, Duchêne M, et al. IgE-binding capacity of recombinant timothy grass (Phleum pratense) pollen allergens. J Allergy Clin Immunol 1994;94:88-94.
57. Laffer S, Valenta R, Vrtala S, et al. Complementary DNA cloning of the major allergen Phl p 1 from timothy grass (Phleum pratense); recombinant Phl p 1 inhibits IgE binding to group I allergens from eight different grass species. J Allergy Clin Immunol 1994;94:689-98.
58. Laffer S, Duchêne M, Reimitzer I, et al. Common IgE-epitopes of recombinant Phl p 1, the major timothy grass pollen allergen, and natural group 1 grass pollen isoallergens. Mol Immunol 1996;33:417-26.
59. Spitzauer S, Pandjaitan B, Mühl S, et al. Major cat and dog allergens share IgE epitopes. J Allergy Clin Immunol 1997;99:100-6.
60. Metzler WJ, Valentine K, Roebber M, Marsh DG, Mueller L. Proton resonance assignments and three-dimensional solution structure of the ragweed allergen Amb a V by nuclear magnetic resonance spectroscopy. Biochemistry 1992;31:8697-8705.
61. Bufe A, Betzel C, Schramm G, et al. Crystallization and preliminary diffraction data of a major pollen allergen: crystal growth separates a low molecular weight form with elevated biological activity. J Biol Chem 1996;271:27193-6.
62. Thorn KS, Christensen HEM, Shigeta R Jr, et al. The crystal structure of a major allergen from plants. Structure 1997;5:19-32.
63. Fedorov AA, Ball T, Valenta R, Almo SC. X-ray crystal structures of birch pollen profilin and Phl p 2. Int Arch Allergy Immunol 1997;113:109-13.
64. Steinberger P, Kraft D, Valenta R. Construction of a combinatorial IgE library from an allergic patient. Isolation and characterization of human IgE Fabs with specificity for the major timothy grass pollen allergen, Phl p 5. J Biol Chem 1996;271:10967-72.
65. Valenta R, Laffer S, Vrtala S, et al. Recombinant allergens. Steps on the way to diagnosis and therapy of type I allergy. In: Sehon A, Hay Glass KT, Kraft D, editors. New horizons in allergy immunotherapy. New York: Plenum Press, 1996: 185-96.
66. Laffer S, Spitzauer S, Susani M, et al. Comparison of recombinant timothy grass pollen allergens with natural extract for diagnosis of grass pollen allergy in different populations. J Allergy Clin Immunol 1996;98:652-8.
67. Rossi RE, Monasterolo G, Operti D, Corsi M. Evaluation of recombinant allergens Bet v 1 and Bet v 2 (profilin) by Pharmacia CAP System in patients with pollen-related allergy to birch and apple. Allergy 1996;51:940-5.
68. Noon L. Prophylactic inoculation for hay-fever. Lancet 1911;1572-3.
69. Bousquet J, Lockey R, Malling H-J. Allergen immunotherapy: therapeutic vaccines for allergic diseases. WHO position paper. Allergy 1998;53:Suppl 44.
70. Ipsen H, Schwartz B, Wihl J-Å. et al. Immunotherapy with partially purified and standardized tree pollen extracts. III. Specific IgE response to the major allergens of alder, birch and hazel pollen during immunotherapy. Allergy 1988;43:370-7.
71. Cooke RA, Bernhard JH, Hebald S, Stull A. Serological evidence of immunity with co-existing sensitization in hay fever type of human allergy. J Exp Med 1935;62:733-50.
72. Loveless MH. Immunological studies of pollinosis. I. The presence of 2 antibodies related to the same pollen-antigen in the serum of treated hay fever patients. J Immunol 1940;38:25-50.
73. Lichtenstein LM, Holtzman NA, Burnett LS. A quantitative in vitro study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody. J Immunol 1968;101:317-24.
74. Aalberse RC, Gaag R, Leeuwen J. Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol 1983;130:722-6.
75. Birkner T, Rumpold H, Jarolim E, et al. Evaluation of immunotherapy-induced changes in specific IgE, IgG and IgG subclasses in birch pollen allergic patients by means of immunoblotting. Correlation with clinical response. Allergy 1990;45:418-26.
76. Vrtala S, Susani M, Sperr WR, et al. Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens (Phl p 1. Phl p 2, Phl p 5). J Allergy Clin Immunol 1996;97:781-7.
77. Tame A, Sakiyama Y, Kobayashi I, Terai I, Kobayashi K. Differences in titres of IgE, IgG4 and other IgG subclass anti-Der p 2 antibodies in allergic and non-allergic patients measured with recombinant allergen. Clin Exp Allergy 1996;26:43-9.
78. Kobayashi I, Sakiyama Y, Tame A, Kobayashi K, Matsumoto S. IgE and IgG4 antibodies from patients with mite allergy recognize different epitopes of Dermatophagoides pteronyssinus group II antigen (Der p 2). J Allergy Clin Immunol 1996;97:638-45.
79. Visco V, Dolecek C, Denepoux S, et al. Human monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1. J Immunol 1996;157:956-62.
80. McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990;348:552-4.
81. Barbas CF III, Kang AS, Lerner RA, Benkovic SJ. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci U S A 1991;88:7978-82.
82. Winter G, Milstein C. Man-made antibodies. Nature 1991;349:293-9.
83. Gram H, Marconi LA, Barbas CF III, Collet TA, Lerner RA, Kang AS. In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library. Proc Natl Acad Sci U S A 1992; 89:3576-80.
84. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin-4 production in CD4+ T cells from allergic individuals. J Exp Med 1993;178:2123-30.
85. 2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 1996;98:1676-83.
86. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Müller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J Immunol 1995;154: 4187-94.
87. McHugh SM, Deighton J, Stewart AJ, Lachmann PF, Ewan PW. Bee venom immunotherapy induces a shift in cytokine responses from a Th2 type to a Th1 dominant pattern: comparison of rush and conventional therapy. Clin Exp Allergy 1995;25:828-38.
88. Smith AM, Chapman MD. Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen Der p 2. Mol Immunol 1996;33:399-405.
89. Takai T, Yokota T, Yasue M, et al. Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy. Nat Biotechnol 1997;15:754-8.
90. Norman PS. Clinical and immunologic effects of component peptides in ALLERVAX CAT. Int Arch Allergy Immunol 1997;113:224-6.
91. Raz E, Tighe H, Sato Y, et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci U S A 1996;2:5141-5.
92. Hsu CH, Chua KY, Tao MH, et al. Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nat Med 1996;2:540-4.